img

Global Human Rabies Vaccination Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Rabies Vaccination Market Insights, Forecast to 2034

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
Global Human Rabies Vaccination market is expected to reach to US$ 1157 million in 2024, with a positive growth of %, compared with US$ 1112 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Human Rabies Vaccination industry is evaluated to reach US$ 1489.5 million in 2029. The CAGR will be 4.3% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Human Rabies Vaccination market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Human Rabies Vaccination market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Segment by Type
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others

Segment by Application


Pre-exposure
Post-exposure

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Human Rabies Vaccination plant distribution, commercial date of Human Rabies Vaccination, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Human Rabies Vaccination introduction, etc. Human Rabies Vaccination Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Human Rabies Vaccination
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Human Rabies Vaccination Product Introduction
1.2 Market by Type
1.2.1 Global Human Rabies Vaccination Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Vero Cell
1.2.3 BHK
1.2.4 Chick Embryo Cell
1.2.5 Human Diploid Cells
1.2.6 Others
1.3 Market by Application
1.3.1 Global Human Rabies Vaccination Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pre-exposure
1.3.3 Post-exposure
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Rabies Vaccination Sales Estimates and Forecasts 2018-2029
2.2 Global Human Rabies Vaccination Revenue by Region
2.2.1 Global Human Rabies Vaccination Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Human Rabies Vaccination Revenue by Region (2018-2024)
2.2.3 Global Human Rabies Vaccination Revenue by Region (2024-2029)
2.2.4 Global Human Rabies Vaccination Revenue Market Share by Region (2018-2029)
2.3 Global Human Rabies Vaccination Sales Estimates and Forecasts 2018-2029
2.4 Global Human Rabies Vaccination Sales by Region
2.4.1 Global Human Rabies Vaccination Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Human Rabies Vaccination Sales by Region (2018-2024)
2.4.3 Global Human Rabies Vaccination Sales by Region (2024-2029)
2.4.4 Global Human Rabies Vaccination Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Human Rabies Vaccination Sales by Manufacturers
3.1.1 Global Human Rabies Vaccination Sales by Manufacturers (2018-2024)
3.1.2 Global Human Rabies Vaccination Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Rabies Vaccination in 2022
3.2 Global Human Rabies Vaccination Revenue by Manufacturers
3.2.1 Global Human Rabies Vaccination Revenue by Manufacturers (2018-2024)
3.2.2 Global Human Rabies Vaccination Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Human Rabies Vaccination Revenue in 2022
3.3 Global Key Players of Human Rabies Vaccination, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Human Rabies Vaccination Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Rabies Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Rabies Vaccination, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Rabies Vaccination, Product Offered and Application
3.8 Global Key Manufacturers of Human Rabies Vaccination, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Rabies Vaccination Sales by Type
4.1.1 Global Human Rabies Vaccination Historical Sales by Type (2018-2024)
4.1.2 Global Human Rabies Vaccination Forecasted Sales by Type (2024-2029)
4.1.3 Global Human Rabies Vaccination Sales Market Share by Type (2018-2029)
4.2 Global Human Rabies Vaccination Revenue by Type
4.2.1 Global Human Rabies Vaccination Historical Revenue by Type (2018-2024)
4.2.2 Global Human Rabies Vaccination Forecasted Revenue by Type (2024-2029)
4.2.3 Global Human Rabies Vaccination Revenue Market Share by Type (2018-2029)
4.3 Global Human Rabies Vaccination Price by Type
4.3.1 Global Human Rabies Vaccination Price by Type (2018-2024)
4.3.2 Global Human Rabies Vaccination Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Human Rabies Vaccination Sales by Application
5.1.1 Global Human Rabies Vaccination Historical Sales by Application (2018-2024)
5.1.2 Global Human Rabies Vaccination Forecasted Sales by Application (2024-2029)
5.1.3 Global Human Rabies Vaccination Sales Market Share by Application (2018-2029)
5.2 Global Human Rabies Vaccination Revenue by Application
5.2.1 Global Human Rabies Vaccination Historical Revenue by Application (2018-2024)
5.2.2 Global Human Rabies Vaccination Forecasted Revenue by Application (2024-2029)
5.2.3 Global Human Rabies Vaccination Revenue Market Share by Application (2018-2029)
5.3 Global Human Rabies Vaccination Price by Application
5.3.1 Global Human Rabies Vaccination Price by Application (2018-2024)
5.3.2 Global Human Rabies Vaccination Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Human Rabies Vaccination Market Size by Type
6.1.1 US & Canada Human Rabies Vaccination Sales by Type (2018-2029)
6.1.2 US & Canada Human Rabies Vaccination Revenue by Type (2018-2029)
6.2 US & Canada Human Rabies Vaccination Market Size by Application
6.2.1 US & Canada Human Rabies Vaccination Sales by Application (2018-2029)
6.2.2 US & Canada Human Rabies Vaccination Revenue by Application (2018-2029)
6.3 US & Canada Human Rabies Vaccination Market Size by Country
6.3.1 US & Canada Human Rabies Vaccination Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Human Rabies Vaccination Sales by Country (2018-2029)
6.3.3 US & Canada Human Rabies Vaccination Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Human Rabies Vaccination Market Size by Type
7.1.1 Europe Human Rabies Vaccination Sales by Type (2018-2029)
7.1.2 Europe Human Rabies Vaccination Revenue by Type (2018-2029)
7.2 Europe Human Rabies Vaccination Market Size by Application
7.2.1 Europe Human Rabies Vaccination Sales by Application (2018-2029)
7.2.2 Europe Human Rabies Vaccination Revenue by Application (2018-2029)
7.3 Europe Human Rabies Vaccination Market Size by Country
7.3.1 Europe Human Rabies Vaccination Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Human Rabies Vaccination Sales by Country (2018-2029)
7.3.3 Europe Human Rabies Vaccination Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Human Rabies Vaccination Market Size
8.1.1 China Human Rabies Vaccination Sales (2018-2029)
8.1.2 China Human Rabies Vaccination Revenue (2018-2029)
8.2 China Human Rabies Vaccination Market Size by Application
8.2.1 China Human Rabies Vaccination Sales by Application (2018-2029)
8.2.2 China Human Rabies Vaccination Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Human Rabies Vaccination Market Size by Type
9.1.1 Asia Human Rabies Vaccination Sales by Type (2018-2029)
9.1.2 Asia Human Rabies Vaccination Revenue by Type (2018-2029)
9.2 Asia Human Rabies Vaccination Market Size by Application
9.2.1 Asia Human Rabies Vaccination Sales by Application (2018-2029)
9.2.2 Asia Human Rabies Vaccination Revenue by Application (2018-2029)
9.3 Asia Human Rabies Vaccination Sales by Region
9.3.1 Asia Human Rabies Vaccination Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Human Rabies Vaccination Revenue by Region (2018-2029)
9.3.3 Asia Human Rabies Vaccination Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Rabies Vaccination Market Size by Type
10.1.1 Middle East, Africa and Latin America Human Rabies Vaccination Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Human Rabies Vaccination Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Human Rabies Vaccination Market Size by Application
10.2.1 Middle East, Africa and Latin America Human Rabies Vaccination Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Human Rabies Vaccination Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Human Rabies Vaccination Sales by Country
10.3.1 Middle East, Africa and Latin America Human Rabies Vaccination Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Human Rabies Vaccination Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Human Rabies Vaccination Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bharat Biotech
11.1.1 Bharat Biotech Company Information
11.1.2 Bharat Biotech Overview
11.1.3 Bharat Biotech Human Rabies Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Bharat Biotech Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bharat Biotech Recent Developments
11.2 Bavarian Nordic
11.2.1 Bavarian Nordic Company Information
11.2.2 Bavarian Nordic Overview
11.2.3 Bavarian Nordic Human Rabies Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Bavarian Nordic Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bavarian Nordic Recent Developments
11.3 Sanofi-Pasteur
11.3.1 Sanofi-Pasteur Company Information
11.3.2 Sanofi-Pasteur Overview
11.3.3 Sanofi-Pasteur Human Rabies Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sanofi-Pasteur Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi-Pasteur Recent Developments
11.4 Chengda Bio
11.4.1 Chengda Bio Company Information
11.4.2 Chengda Bio Overview
11.4.3 Chengda Bio Human Rabies Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Chengda Bio Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Chengda Bio Recent Developments
11.5 KANGH
11.5.1 KANGH Company Information
11.5.2 KANGH Overview
11.5.3 KANGH Human Rabies Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 KANGH Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 KANGH Recent Developments
11.6 Prcmise
11.6.1 Prcmise Company Information
11.6.2 Prcmise Overview
11.6.3 Prcmise Human Rabies Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Prcmise Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Prcmise Recent Developments
11.7 Henan Grand Biopharma
11.7.1 Henan Grand Biopharma Company Information
11.7.2 Henan Grand Biopharma Overview
11.7.3 Henan Grand Biopharma Human Rabies Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Henan Grand Biopharma Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Henan Grand Biopharma Recent Developments
11.8 Zhuoyi Biological
11.8.1 Zhuoyi Biological Company Information
11.8.2 Zhuoyi Biological Overview
11.8.3 Zhuoyi Biological Human Rabies Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Zhuoyi Biological Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zhuoyi Biological Recent Developments
11.9 ZhongKe Biopharm
11.9.1 ZhongKe Biopharm Company Information
11.9.2 ZhongKe Biopharm Overview
11.9.3 ZhongKe Biopharm Human Rabies Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 ZhongKe Biopharm Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 ZhongKe Biopharm Recent Developments
11.10 Ningbo Rongan Biological
11.10.1 Ningbo Rongan Biological Company Information
11.10.2 Ningbo Rongan Biological Overview
11.10.3 Ningbo Rongan Biological Human Rabies Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Ningbo Rongan Biological Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ningbo Rongan Biological Recent Developments
11.11 Indian Immunologicals
11.11.1 Indian Immunologicals Company Information
11.11.2 Indian Immunologicals Overview
11.11.3 Indian Immunologicals Human Rabies Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Indian Immunologicals Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Indian Immunologicals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Rabies Vaccination Industry Chain Analysis
12.2 Human Rabies Vaccination Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Rabies Vaccination Production Mode & Process
12.4 Human Rabies Vaccination Sales and Marketing
12.4.1 Human Rabies Vaccination Sales Channels
12.4.2 Human Rabies Vaccination Distributors
12.5 Human Rabies Vaccination Customers
13 Market Dynamics
13.1 Human Rabies Vaccination Industry Trends
13.2 Human Rabies Vaccination Market Drivers
13.3 Human Rabies Vaccination Market Challenges
13.4 Human Rabies Vaccination Market Restraints
14 Key Findings in The Global Human Rabies Vaccination Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Rabies Vaccination Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Vero Cell
Table 3. Major Manufacturers of BHK
Table 4. Major Manufacturers of Chick Embryo Cell
Table 5. Major Manufacturers of Human Diploid Cells
Table 6. Major Manufacturers of Others
Table 7. Global Human Rabies Vaccination Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Human Rabies Vaccination Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Human Rabies Vaccination Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Human Rabies Vaccination Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Human Rabies Vaccination Revenue Market Share by Region (2018-2024)
Table 12. Global Human Rabies Vaccination Revenue Market Share by Region (2024-2029)
Table 13. Global Human Rabies Vaccination Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Human Rabies Vaccination Sales by Region (2018-2024) & (K Units)
Table 15. Global Human Rabies Vaccination Sales by Region (2024-2029) & (K Units)
Table 16. Global Human Rabies Vaccination Sales Market Share by Region (2018-2024)
Table 17. Global Human Rabies Vaccination Sales Market Share by Region (2024-2029)
Table 18. Global Human Rabies Vaccination Sales by Manufacturers (2018-2024) & (K Units)
Table 19. Global Human Rabies Vaccination Sales Share by Manufacturers (2018-2024)
Table 20. Global Human Rabies Vaccination Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Human Rabies Vaccination Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Human Rabies Vaccination, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Human Rabies Vaccination Price by Manufacturers 2018-2024 (US$/Unit)
Table 24. Global Human Rabies Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Human Rabies Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Vaccination as of 2022)
Table 26. Global Key Manufacturers of Human Rabies Vaccination, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Human Rabies Vaccination, Product Offered and Application
Table 28. Global Key Manufacturers of Human Rabies Vaccination, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Human Rabies Vaccination Sales by Type (2018-2024) & (K Units)
Table 31. Global Human Rabies Vaccination Sales by Type (2024-2029) & (K Units)
Table 32. Global Human Rabies Vaccination Sales Share by Type (2018-2024)
Table 33. Global Human Rabies Vaccination Sales Share by Type (2024-2029)
Table 34. Global Human Rabies Vaccination Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Human Rabies Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Human Rabies Vaccination Revenue Share by Type (2018-2024)
Table 37. Global Human Rabies Vaccination Revenue Share by Type (2024-2029)
Table 38. Human Rabies Vaccination Price by Type (2018-2024) & (US$/Unit)
Table 39. Global Human Rabies Vaccination Price Forecast by Type (2024-2029) & (US$/Unit)
Table 40. Global Human Rabies Vaccination Sales by Application (2018-2024) & (K Units)
Table 41. Global Human Rabies Vaccination Sales by Application (2024-2029) & (K Units)
Table 42. Global Human Rabies Vaccination Sales Share by Application (2018-2024)
Table 43. Global Human Rabies Vaccination Sales Share by Application (2024-2029)
Table 44. Global Human Rabies Vaccination Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Human Rabies Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Human Rabies Vaccination Revenue Share by Application (2018-2024)
Table 47. Global Human Rabies Vaccination Revenue Share by Application (2024-2029)
Table 48. Human Rabies Vaccination Price by Application (2018-2024) & (US$/Unit)
Table 49. Global Human Rabies Vaccination Price Forecast by Application (2024-2029) & (US$/Unit)
Table 50. US & Canada Human Rabies Vaccination Sales by Type (2018-2024) & (K Units)
Table 51. US & Canada Human Rabies Vaccination Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Human Rabies Vaccination Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Human Rabies Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Human Rabies Vaccination Sales by Application (2018-2024) & (K Units)
Table 55. US & Canada Human Rabies Vaccination Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Human Rabies Vaccination Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Human Rabies Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Human Rabies Vaccination Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Human Rabies Vaccination Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Human Rabies Vaccination Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Human Rabies Vaccination Sales by Country (2018-2024) & (K Units)
Table 62. US & Canada Human Rabies Vaccination Sales by Country (2024-2029) & (K Units)
Table 63. Europe Human Rabies Vaccination Sales by Type (2018-2024) & (K Units)
Table 64. Europe Human Rabies Vaccination Sales by Type (2024-2029) & (K Units)
Table 65. Europe Human Rabies Vaccination Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Human Rabies Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Human Rabies Vaccination Sales by Application (2018-2024) & (K Units)
Table 68. Europe Human Rabies Vaccination Sales by Application (2024-2029) & (K Units)
Table 69. Europe Human Rabies Vaccination Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Human Rabies Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Human Rabies Vaccination Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Human Rabies Vaccination Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Human Rabies Vaccination Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Human Rabies Vaccination Sales by Country (2018-2024) & (K Units)
Table 75. Europe Human Rabies Vaccination Sales by Country (2024-2029) & (K Units)
Table 76. China Human Rabies Vaccination Sales by Type (2018-2024) & (K Units)
Table 77. China Human Rabies Vaccination Sales by Type (2024-2029) & (K Units)
Table 78. China Human Rabies Vaccination Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Human Rabies Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Human Rabies Vaccination Sales by Application (2018-2024) & (K Units)
Table 81. China Human Rabies Vaccination Sales by Application (2024-2029) & (K Units)
Table 82. China Human Rabies Vaccination Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Human Rabies Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Human Rabies Vaccination Sales by Type (2018-2024) & (K Units)
Table 85. Asia Human Rabies Vaccination Sales by Type (2024-2029) & (K Units)
Table 86. Asia Human Rabies Vaccination Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Human Rabies Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Human Rabies Vaccination Sales by Application (2018-2024) & (K Units)
Table 89. Asia Human Rabies Vaccination Sales by Application (2024-2029) & (K Units)
Table 90. Asia Human Rabies Vaccination Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Human Rabies Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Human Rabies Vaccination Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Human Rabies Vaccination Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Human Rabies Vaccination Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Human Rabies Vaccination Sales by Region (2018-2024) & (K Units)
Table 96. Asia Human Rabies Vaccination Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Human Rabies Vaccination Sales by Type (2018-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Human Rabies Vaccination Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Human Rabies Vaccination Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Human Rabies Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Human Rabies Vaccination Sales by Application (2018-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Human Rabies Vaccination Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Human Rabies Vaccination Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Human Rabies Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Human Rabies Vaccination Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Human Rabies Vaccination Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Human Rabies Vaccination Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Human Rabies Vaccination Sales by Country (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Human Rabies Vaccination Sales by Country (2024-2029) & (K Units)
Table 110. Bharat Biotech Company Information
Table 111. Bharat Biotech Description and Major Businesses
Table 112. Bharat Biotech Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Bharat Biotech Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bharat Biotech Recent Developments
Table 115. Bavarian Nordic Company Information
Table 116. Bavarian Nordic Description and Major Businesses
Table 117. Bavarian Nordic Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Bavarian Nordic Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Bavarian Nordic Recent Developments
Table 120. Sanofi-Pasteur Company Information
Table 121. Sanofi-Pasteur Description and Major Businesses
Table 122. Sanofi-Pasteur Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Sanofi-Pasteur Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sanofi-Pasteur Recent Developments
Table 125. Chengda Bio Company Information
Table 126. Chengda Bio Description and Major Businesses
Table 127. Chengda Bio Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Chengda Bio Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Chengda Bio Recent Developments
Table 130. KANGH Company Information
Table 131. KANGH Description and Major Businesses
Table 132. KANGH Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. KANGH Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. KANGH Recent Developments
Table 135. Prcmise Company Information
Table 136. Prcmise Description and Major Businesses
Table 137. Prcmise Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Prcmise Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Prcmise Recent Developments
Table 140. Henan Grand Biopharma Company Information
Table 141. Henan Grand Biopharma Description and Major Businesses
Table 142. Henan Grand Biopharma Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Henan Grand Biopharma Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Henan Grand Biopharma Recent Developments
Table 145. Zhuoyi Biological Company Information
Table 146. Zhuoyi Biological Description and Major Businesses
Table 147. Zhuoyi Biological Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Zhuoyi Biological Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Zhuoyi Biological Recent Developments
Table 150. ZhongKe Biopharm Company Information
Table 151. ZhongKe Biopharm Description and Major Businesses
Table 152. ZhongKe Biopharm Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. ZhongKe Biopharm Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. ZhongKe Biopharm Recent Developments
Table 155. Ningbo Rongan Biological Company Information
Table 156. Ningbo Rongan Biological Description and Major Businesses
Table 157. Ningbo Rongan Biological Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Ningbo Rongan Biological Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Ningbo Rongan Biological Recent Developments
Table 160. Indian Immunologicals Company Information
Table 161. Indian Immunologicals Description and Major Businesses
Table 162. Indian Immunologicals Human Rabies Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Indian Immunologicals Human Rabies Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Indian Immunologicals Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Human Rabies Vaccination Distributors List
Table 168. Human Rabies Vaccination Customers List
Table 169. Human Rabies Vaccination Market Trends
Table 170. Human Rabies Vaccination Market Drivers
Table 171. Human Rabies Vaccination Market Challenges
Table 172. Human Rabies Vaccination Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Rabies Vaccination Product Picture
Figure 2. Global Human Rabies Vaccination Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Human Rabies Vaccination Market Share by Type in 2022 & 2029
Figure 4. Vero Cell Product Picture
Figure 5. BHK Product Picture
Figure 6. Chick Embryo Cell Product Picture
Figure 7. Human Diploid Cells Product Picture
Figure 8. Others Product Picture
Figure 9. Global Human Rabies Vaccination Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Human Rabies Vaccination Market Share by Application in 2022 & 2029
Figure 11. Pre-exposure
Figure 12. Post-exposure
Figure 13. Human Rabies Vaccination Report Years Considered
Figure 14. Global Human Rabies Vaccination Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Human Rabies Vaccination Revenue 2018-2029 (US$ Million)
Figure 16. Global Human Rabies Vaccination Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Human Rabies Vaccination Revenue Market Share by Region (2018-2029)
Figure 18. Global Human Rabies Vaccination Sales 2018-2029 ((K Units)
Figure 19. Global Human Rabies Vaccination Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Human Rabies Vaccination Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Human Rabies Vaccination Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Human Rabies Vaccination Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Human Rabies Vaccination Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Human Rabies Vaccination Sales YoY (2018-2029) & (K Units)
Figure 25. China Human Rabies Vaccination Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Human Rabies Vaccination Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Human Rabies Vaccination Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Human Rabies Vaccination Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Human Rabies Vaccination Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Human Rabies Vaccination Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Human Rabies Vaccination in the World: Market Share by Human Rabies Vaccination Revenue in 2022
Figure 32. Global Human Rabies Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Human Rabies Vaccination Sales Market Share by Type (2018-2029)
Figure 34. Global Human Rabies Vaccination Revenue Market Share by Type (2018-2029)
Figure 35. Global Human Rabies Vaccination Sales Market Share by Application (2018-2029)
Figure 36. Global Human Rabies Vaccination Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Human Rabies Vaccination Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Human Rabies Vaccination Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Human Rabies Vaccination Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Human Rabies Vaccination Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Human Rabies Vaccination Revenue Share by Country (2018-2029)
Figure 42. US & Canada Human Rabies Vaccination Sales Share by Country (2018-2029)
Figure 43. U.S. Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Human Rabies Vaccination Sales Market Share by Type (2018-2029)
Figure 46. Europe Human Rabies Vaccination Revenue Market Share by Type (2018-2029)
Figure 47. Europe Human Rabies Vaccination Sales Market Share by Application (2018-2029)
Figure 48. Europe Human Rabies Vaccination Revenue Market Share by Application (2018-2029)
Figure 49. Europe Human Rabies Vaccination Revenue Share by Country (2018-2029)
Figure 50. Europe Human Rabies Vaccination Sales Share by Country (2018-2029)
Figure 51. Germany Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 52. France Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 56. China Human Rabies Vaccination Sales Market Share by Type (2018-2029)
Figure 57. China Human Rabies Vaccination Revenue Market Share by Type (2018-2029)
Figure 58. China Human Rabies Vaccination Sales Market Share by Application (2018-2029)
Figure 59. China Human Rabies Vaccination Revenue Market Share by Application (2018-2029)
Figure 60. Asia Human Rabies Vaccination Sales Market Share by Type (2018-2029)
Figure 61. Asia Human Rabies Vaccination Revenue Market Share by Type (2018-2029)
Figure 62. Asia Human Rabies Vaccination Sales Market Share by Application (2018-2029)
Figure 63. Asia Human Rabies Vaccination Revenue Market Share by Application (2018-2029)
Figure 64. Asia Human Rabies Vaccination Revenue Share by Region (2018-2029)
Figure 65. Asia Human Rabies Vaccination Sales Share by Region (2018-2029)
Figure 66. Japan Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 70. India Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Human Rabies Vaccination Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Human Rabies Vaccination Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Human Rabies Vaccination Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Human Rabies Vaccination Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Human Rabies Vaccination Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Human Rabies Vaccination Sales Share by Country (2018-2029)
Figure 77. Brazil Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Human Rabies Vaccination Revenue (2018-2029) & (US$ Million)
Figure 82. Human Rabies Vaccination Value Chain
Figure 83. Human Rabies Vaccination Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries